ENTA - Enanta Pharmaceuticals Inc
IEX Last Trade
12.91
-0.110 -0.852%
Share volume: 111,336
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.02
-0.11
-0.85%
Summary score
16%
Profitability
18%
Dept financing
12%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.46%
Return on assets
-7.15%
Return on sales
-148.51%
Return on invested capital
-55.99%
Total debt ratio
21.14%
Debt ratio change over timeo
-1.03%
Current Ratio
11.34%
Quick Ratio
11.34%
Cash Position Ratio
9.48%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.27%
Return on assets
-7.55%
Return on sales
-186.04%
Return on invested capital
11.76%
Total debt ratio
54.72%
Debt ratio change over timeo
-0.75%
Current Ratio
6.5%
Quick Ratio
6.5%
Cash Position Ratio
5.62%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-18.6%
Return on assets
-7.92%
Return on sales
-192.13%
Return on invested capital
-393.4%
Total debt ratio
59.49%
Debt ratio change over time
-0.57%
Current Ratio
6.43%
Quick Ratio
6.43%
Cash Position Ratio
5.5%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.82%
Return on assets
-92.99%
Return on sales
34.89%
Return on invested capital
-62.49%
Total debt ratio
-103.09%
Debt ratio change over time
-1.03%
Current Ratio
-5.99%
Quick Ratio
-5.99%
Cash Position Ratio
-4.62%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ENTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.46% | 15.05% | 35.64% | 7.13% |
| Return on assets | -7.15% | 2.88% | 3.13% | 5.53% |
| Return on sales | -148.51% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -55.99% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 21.14% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.03% | 326.95% | -8.44% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 6.5% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 6.5% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.62% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 5% | 10% | 25% |
| Short-term ratios | ENTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.27% | 13.14% | 10.88% | 4.07% |
| Return on assets | -7.55% | 2.1% | 1.54% | 3.03% |
| Return on sales | -186.04% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 11.76% | 1.95% | 2.74% | 9.55% |
| Profitability | 25% | 64% | 54% | 78% |
| Total debt ratio | 54.72% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.75% | 51.04% | -101.54% | 1.43% |
| Dept financing | 15% | 50% | 25% | 7% |
| Current Ratio | 6.5% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 6.5% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 5.62% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 8% | 18% | 51% |